The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, today announced a collaboration to develop a novel analytical platform to improve the rapid analysis of the glycosylation profiles of biotherapeutics. This is a critical quality attribute which is important for the efficacy and safety of these molecules. The consortium brings […]

Signs Master Collaboration Agreement for Assay Development and Manufacturing of Kits Supporting Biomarker Research Programs TUCSON, Ariz. and DARMSTADT, Germany — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications today announced a new Master Collaboration Agreement for translational programs with Merck KGaA, Darmstadt, Germany, a leading science and technology company. The Master Collaboration Agreement […]

Helsinki – MediSapiens, a leading developer and provider of genomic, biomedical and healthcare data solutions, joins the recently announced 59M€ FinnGen project, that aims at improving human health through genetically profiling 500.000 Finns, and combining that with a rich set of clinical data to identify new therapeutic targets, as well as diagnostic and prognostic markers […]

NDF and PerkinElmer to collaborate on a deeper look at GNE Myopathy BEVERLY HILLS, Calif. The Neuromuscular Disease Foundation (NDF) – the world’s leading nonprofit organization focused on the rare genetic disease called GNE Myopathy (GNEM, also known as HIBM) is pleased to announce its collaboration with PerkinElmer for Whole Genome Sequencing (WGS) paired with […]

NGS platform to generate additional clinical data to build out the Skyline-Helomics D-CHIP bioinformatics platform MINNEAPOLIS — Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced that it is expanding into Next Generation Sequencing (“NGS”) through the licensing of an NGS platform MiSeqDx®, from Illumina. […]

CAMBRIDGE, Mass. and PHILADELPHIA, PA — Ovation.io, Inc. (Ovation), makers of the fastest-growing clinical laboratory information and commercialization platform, and Coriell Life Sciences, Inc., an innovative provider of clinical genetic reporting solutions, announced today a partnership and platform integration designed to create a seamless ecosystem for sample and workflow management, genetic data interpretation, and external client […]

Bright Angel Therapeutics to leverage Schrödinger’s best-in-class drug discovery platforms to develop novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections New York, NY and Toronto, Canada – Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, and MaRS Innovation, a non-profit organization supporting the commercialization of research breakthroughs […]

— Aims to accelerate manufacturing of new treatments for broad range of serious diseases — Underscores MilliporeSigma as a leading contract manufacturing organization and commercial provider of viral vectors for gene therapy BURLINGTON, Mass. — MilliporeSigma today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, Massachusetts, for […]

WALTHAM, Mass. — Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher’s Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T) therapies. Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 […]

Innovative enterprise platform for clinical cross-omics now also accessible via high-performance cloud computing services Microsoft Azure and Amazon Web Services Basel, Switzerland Genedata, a leading provider of advanced software solutions for biopharmaceutical research and development (R&D), today announced that Genedata ProfilerTM, its leading enterprise software platform for omics-based profiling of patients in translational and clinical […]